GoodRx Holdings Inc - Class A

NASDAQ: GDRX
$4.70
-$0.19 (-3.9%)
Closing Price on November 12, 2024

GDRX Stock Chart and Intraday Price

GDRX Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector TECHNOLOGY
Industry SERVICES-COMPUTER PROCESSING & DATA PREPARATION
Address 233 WILSHIRE BLVD., SUITE 990, SANTA MONICA, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 3,391.20M USD
Shares Outstanding 92,400,000
GoodRx Holdings Inc provides a platform that helps consumers in the United States save on prescription drugs. By offering a price comparison tool, GoodRx enables users to find the best prices for their medications, access discounts, and even enjoy additional healthcare services such as telehealth. Founded in 2015 and based in Santa Monica, California, the company simplifies the process of finding affordable prescriptions and healthcare products for millions of people.

GDRX Articles

Analysts on average recommend buying these nine cheap stocks in a variety of sectors. Their consensus price targets suggest double-digit gains in the coming year.
Friday's top analyst upgrades and downgrades included AppLovin, Crown Castle, GoodRx, Global Payments, Monster Beverage, Penn Entertainment, Plug Power, Roblox, Southern Company and Wynn Resorts.
Thursday’s additional top analyst upgrades and downgrades were on Ally Financial, Altimmune, Capital One Financial, GoodRx, Leslie’s, PagSeguro Digital, Regions Financial, Sirius XM, StoneCo,...
Thursday's top analyst upgrades and downgrades included Affirm, Coinbase Global, Dominion Energy, GoodRx, Kroger, Nasdaq, Plug Power, PubMatic, Tyson Foods and Walt Disney.
Monday's top analyst upgrades and downgrades included Altice USA, Arista Networks, Block, Cardinal Health, ConocoPhillips, Datadog, GoodRx, Monster Beverage, PepsiCo, Spirit AeroSystems, Twilio and...
Wednesday's additional top analyst upgrades and downgrades were on AstraZeneca, Bilibili, Electronic Arts, GoodRx, NetEase, Netflix, Pinterest, U.S. Foods and more.
Monday’s top analyst upgrades and downgrades included Archer Daniels Midland, Crowdstrike, GoodRx, Illumina, Oracle, Payoneer Global, Palo Alto Networks, Playa Hotels, Rivian Automotive,...
Wednesday’s top analyst upgrades and downgrades included Amgen, Bed Bath & Beyond, Carlyle, Coinbase Global, Enovix, GoodRx, Healthcare Realty Trust, Micron Technology, NRG Energy, Nutrien, Nvidia,...
Monday's top analyst upgrades and downgrades included Docusign, Electronic Arts, Enterprise Products Partners, GoodRx, Netflix, Spirit Airlines, Take-Two Interactive Software, Target, Tesla and...
Tuesday's top analyst upgrades and downgrades included Best Buy, Cigna, Exxon Mobil, Futu, GoodRx, Lululemon Athletica, Merck, Monster Beverage, MP Materials, Nike, Visa and Walmart.
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with...
Wednesday’s additional top analyst upgrades and downgrades were on Danaher, eBay, GoodRx, Infosys, Valero Energy, Xylem and more.
Wednesday's top analyst upgrades and downgrades included Affirm, Bausch + Lomb, Electronic Arts, EOG Resources, Foot Locker, Ford, GoodRx, Goodyear Tire, Healthcare Trust of America, Simon Property,...
Tuesday’s additional top analyst upgrades and downgrades were on Affirm, Edison International, GoodRx, LivePerson, Palantir Technologies, Progressive, Upstart and more.
Wednesday's top analyst upgrades and downgrades included Block, Boeing, Cemex, Constellation Brands, FirstEnergy, Freeport-McMoRan, GoodRx, Hasbro, Kosmos Energy, PayPal, Shopify, Starbucks, Toast...